About Coriolis Pharma
Coriolis Pharma is a company based in Planegg (Germany) founded in 2008. Coriolis Pharma offers products and services including Drug Product Development, Analytical Services, and Manufacturing Services. Coriolis Pharma operates in a competitive market with competitors including KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others.
- Headquarter Planegg, Germany
- SectorsHealthcare
- Phone•••• ••••
- Website coriolis-pharma.com
- Social LinkedIn
- Legal Name Coriolis Pharma Research Gmbh
- Investors
Products & Services of Coriolis Pharma
Coriolis Pharma offers a comprehensive portfolio of products and services, including Drug Product Development, Analytical Services, and Manufacturing Services.
Optimizes drug stability and efficacy for biologics in vials and syringes.
Provides comprehensive testing for regulatory compliance in biologics.
Supports GMP development for biologics and advanced therapies.
Funding Insights of Coriolis Pharma
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Coriolis Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2023 | – | Seed | – | KKR | – |
1 investors in total: 1 institutional.
Investors in Coriolis Pharma
Coriolis Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include KKR.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multiple sectors are invested in by this private equity firm. | 1976 | kkr.com | New York, United States |
Investor details for Coriolis Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Coriolis Pharma
55 people are tracked at Coriolis Pharma (3 in leadership, 52 in team).
| Name | Role | Group |
|---|---|---|
Silvia Steyrer-Gruber | Chief Executive Officer | Leadership |
Andrea Hawe | Chief Scientific Officer | Leadership |
Frank Schaubhut | Pharmacist, Chief Operating Officer | Leadership |
Katharina Kolland | Project Manager PMO | Team |
Andreas Stelzl | Client Project Manager | Team |
Teresa Eichenlaub | Client Project Manager | Team |
Klingler Stefan | Project Leader | Team |
Thomas L. | Expert Scientist | Team |
Daniel D. | Senior Scientist | Team |
Themistoklis Zisis | Scientist | Team |
Maitê Harguindeguy | Scientist - Lyophilization | Team |
Katharina Lamm | Projektmanager | Team |
Carina Schludi | Scientist | Team |
Arindam Ghosh | Scientific Application Specialist | Team |
Angelika Reichel | Apotheker, Scientific Review, GRP Manager | Team |
Constanze Helbig | Senior Scientist | Team |
Stefan Lehnert | Senior Scientist / Team Lead | Team |
André São Pedro | Formulation Scientist | Team |
Daniela Stadler | Scientist | Team |
Brecht Vanbillemont | Senior Scientist - US | Team |
35 more people are available in the full profile.
Complete people profiles for Coriolis Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Coriolis Pharma
2 dated milestones of Coriolis Pharma across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Coriolis Pharma is founded.
- Funding First funding round.
Competitors of Coriolis Pharma
Coriolis Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kbibiopharma.com | 1996 | Durham, United States | $18.29M | 1,243 | Provider of protein formulation, process & cell line development, and cGMP services | |
| aldevron.com | 1998 | Fargo, United States | – | 747 | Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications | |
| kemwellbiopharma.com | 1980 | Bengaluru, India | $5.72M | 298 | Integrated biologics development and manufacturing are provided as a CDMO. | |
| eurogentec.com | 1985 | Seraing, Belgium | – | 426 | Oligonucleotides, peptides, and antibodies are developed and manufactured by Eurogentec. | |
| ovagen.ie | 2000 | Mayo, Ireland | $25.21M | – | Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services | |
| laurus.bio | 2005 | Bengaluru, India | $18.89M | 6,094 | Precision fermentation services for biopharma and food are provided. | |
| idt-biologika.com | 1921 | Dessau Rosslau, Germany | – | – | Vaccines and biologics are developed and manufactured by IDT Biologika. | |
| eirgenix.com | 2012 | Taipei, Taiwan | $90.58M | – | Biologics development and manufacturing services are offered by EirGenix. | |
| omniabio.com | 2001 | Rockville, United States | $25.4M | – | Process development and manufacturing services for biologics are provided. |
Detailed competitors of Coriolis Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Coriolis Pharma
The website of Coriolis Pharma (coriolis-pharma.com) receives about 6.6K visits a month.
- Monthly visits6.6K
▼ 7% vs previous month
Websites whose visitors overlap most with Coriolis Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
cd-bioparticles.net | cd-bioparticles.net | 100% | – | #946,380 | – |
| dynamic-biosensors.com | 95% | 5.4K | #3,616,832 | View details | |
| labx.com | 91% | – | #191,580 | View details | |
| nanion.de | 86% | 13.2K | #1,841,615 | View details | |
| nanotempertech.com | 85% | 29.5K | #979,202 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 17 similar websites and full traffic analytics for Coriolis Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 17 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Coriolis Pharma
Complete news archive for Coriolis Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Coriolis Pharma
10 companies that operate in the same segment as Coriolis Pharma (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Coriolis Pharma
Coriolis Pharma was founded in 2008 and raised its 1st funding round 15 years after it was founded.
Coriolis Pharma is headquartered in Planegg, Germany. It is registered at Planegg, Bavaria, Germany.
The company was founded in 2008 and is based in Planegg, Germany. GMP-compliant services as a CROCDO are provided, focusing on biopharmaceutical formulation development for proteins, peptides, and vaccines. Operations encompass formulation research, analytical method development, forced degradation and stability studies, lyophilization, and aggregatesparticle analysis including protein aggregation and subvisible particle testing. Contract analytical services utilize techniques such as circular dichroism, HPLC, UPLC, and differential scanning fluorimetry.
Coriolis Pharma's top competitors include KBI Biopharma, Aldevron and Ovagen.
Coriolis Pharma offers Drug Product Development, Analytical Services, and Manufacturing Services.
Coriolis Pharma has 1 investor. Key investors include KKR.
Coriolis Pharma operates through Coriolis Pharma Research Gmbh.